1.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Review on the t(6;11)(q27;q23) involving KMT2A (better known as MLL), and AFDN (Afadin), also known as AF6 or MLLT4. It occurs in acute myeloid leukemia, at times treatment-related leukemia, B lymphoblastic leukemia, and T-cell lymphoblastic leukemia. It carries a poor prognosis.
No bibliography items were found for this article.
Atlas Genet Cytogenet Oncol Haematol. 2017-07-01
Online version: http://atlasgeneticsoncology.org/haematological/1015/t(6;11)(q27;q23)-kmt2a-afdn
1997-11-01 t(6;11)(q27;q23) KMT2A/AFDN by Jean-Loup Huret,Jean-Loup Huret